Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R01CA179243 | U.S. NIH Grant/Contract | View source | |
| 18-009965 | Other Identifier | Mayo Clinic in Rohester | |
| P30CA015083 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institutes of Health (NIH) | NIH |
| National Cancer Institute (NCI) | NIH |
Not provided
Not provided
Not provided
Not provided
Researchers are trying to determine whether certain microbiome cause cancer or whether they are part of the microbiome in the gut due to the presence of cancer.
The purpose of this research is to learn about how the gastrointestinal bacteria (microbiome) can contribute to colon cancer, and how it may change due to colon cancer. In addition, we are going to study the features of the microbiome that can help predict recovery after colon resection. To do this, we are going to compare the microbiome from subjects with colon cancer to subjects without colon cancer.
Study participation involves collection of stool samples before and after your surgery, as well as samples of residual (left-over) colon tissue from your surgery. We would also like to collect optional samples from your follow-up colonoscopy. You may be in the study for up to 5 years.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Colorectal Cancer Subjects | Subjects under going colorectal resection with colorectal cancer will have tissue and stool collected | ||
| Benign Colon Resection Subjects | Subjects under going colorectal resection without colorectal cancer will have tissue and stool collected |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| DNA/RNA Biomarkers | Biomarkers will be defined by extracting DNA/RNA from tissue biopsies and stored for specific gene extractions. | 5 years |
| Microbial 16S rDNA Biomarkers | The samples will be used to partially (V3-V5 region) amplify the microbial 16S rDNA genes through a polymerase chain reaction (PCR). The PCR product will subsequently be purified and quantified before being sequenced. They will also be used for whole genome sequencing (WGS) and Methylation sequencing (Methyl-Seq). The RNA will be used for RNAseq. | 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Protein Measurements | Based on our initial findings protein measurements may also be performed on any extra residual specimens. | 5 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Subjects undergoing bowel resection by any standard surgical approach at Mayo Clinic in Rochester, MN.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Nicholas L. Chia, Ph.D. | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | United States |
Not provided
| Label | URL |
|---|---|
| Mayo Clinic Clinical Trials | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003110 | Colonic Neoplasms |
| D005767 | Gastrointestinal Diseases |
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Tissue Biopsy
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |